Hubertus von Baumbach (#607)
- $ 7 B
- Pharma
- Germany
- M
- 58 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Hubertus von Baumbach is the chairman of Boehringer Ingelheim, the world's largest private pharmaceutical company, headquartered in Germany. Founded in 1885 by Albert Boehringer, the company supplied ingredients to pharmacies, textile merchants and the food industry, and grew to a workforce of 1,500 by 1939. In 1917 the company opened a research department with chemist Heinrich Wieland, Boehringer's cousin, who went on to win the Nobel Prize in Chemistry. An heir to the fortune, von Baumbach joined the company in 2001 and became its chairman in 2016. Today, Boehringer Ingelheim's most well-known drugs treat COPD, anti-coagulation and type 2 diabetes; it now employs 53,000 people and has a presence in 130 markets. Von Baumbach along with 14 members of the family own equal parts of the company.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Hubertus von Baumbach’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Hubertus von Baumbach’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $6.6B
(May 4, 2026)
© Iconic Billionaires